Search research articles
Contact Us
Filters
Showing results (311-320 of 358) with videos related to
Page
of 36
Sort By:
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
NPJ Vaccines
|
April 18, 2026
Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine
Holly Janes, Youyi Fong, Ying Huang, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Nature Communications
|
May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
David C Montefiori, Chitraporn Karnasuta, Ying Huang, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 358) with videos related to
Sort By:
Page
of 36
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection
James I Mullins, Wenjie Deng, Elena E Giorgi, et al.
NPJ Vaccines
|
April 18, 2026
Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine
Holly Janes, Youyi Fong, Ying Huang, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Nature Communications
|
May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
David C Montefiori, Chitraporn Karnasuta, Ying Huang, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Page
of 36